Md Shajedur Rahman Shawon1, Michael Odutola2, Michael O Falster2, Louisa R Jorm2. 1. Centre for Big Data Research in Health, University of New South Wales (UNSW) Sydney, Kensington, Australia. s.shawon@unsw.edu.au. 2. Centre for Big Data Research in Health, University of New South Wales (UNSW) Sydney, Kensington, Australia.
Abstract
BACKGROUND: Readmission after coronary artery bypass graft (CABG) surgery is associated with adverse outcomes and significant healthcare costs, and 30-day readmission rate is considered as a key indicator of the quality of care. This study aims to: quantify rates of readmission within 30 days of CABG surgery; explore the causes of readmissions; and investigate how patient- and hospital-level factors influence readmission. METHODS: We conducted systematic searches (until June 2020) of PubMed and Embase databases to retrieve observational studies that investigated readmission after CABG. Random effect meta-analysis was used to estimate rates and predictors of 30-day post-CABG readmission. RESULTS: In total, 53 studies meeting inclusion criteria were identified, including 8,937,457 CABG patients. The pooled 30-day readmission rate was 12.9% (95% CI: 11.3-14.4%). The most frequently reported underlying causes of 30-day readmissions were infection and sepsis (range: 6.9-28.6%), cardiac arrythmia (4.5-26.7%), congestive heart failure (5.8-15.7%), respiratory complications (1-20%) and pleural effusion (0.4-22.5%). Individual factors including age (OR per 10-year increase 1.12 [95% CI: 1.04-1.20]), female sex (OR 1.29 [1.25-1.34]), non-White race (OR 1.15 [1.10-1.21]), not having private insurance (OR 1.39 [1.27-1.51]) and various comorbidities were strongly associated with 30-day readmission rates, whereas associations with hospital factors including hospital CABG volume, surgeon CABG volume, hospital size, hospital quality and teaching status were inconsistent. CONCLUSIONS: Nearly 1 in 8 CABG patients are readmitted within 30 days and the majority of these are readmitted for noncardiac causes. Readmission rates are strongly influenced by patients' demographic and clinical characteristics, but not by broadly defined hospital characteristics.
BACKGROUND: Readmission after coronary artery bypass graft (CABG) surgery is associated with adverse outcomes and significant healthcare costs, and 30-day readmission rate is considered as a key indicator of the quality of care. This study aims to: quantify rates of readmission within 30 days of CABG surgery; explore the causes of readmissions; and investigate how patient- and hospital-level factors influence readmission. METHODS: We conducted systematic searches (until June 2020) of PubMed and Embase databases to retrieve observational studies that investigated readmission after CABG. Random effect meta-analysis was used to estimate rates and predictors of 30-day post-CABG readmission. RESULTS: In total, 53 studies meeting inclusion criteria were identified, including 8,937,457 CABG patients. The pooled 30-day readmission rate was 12.9% (95% CI: 11.3-14.4%). The most frequently reported underlying causes of 30-day readmissions were infection and sepsis (range: 6.9-28.6%), cardiac arrythmia (4.5-26.7%), congestive heart failure (5.8-15.7%), respiratory complications (1-20%) and pleural effusion (0.4-22.5%). Individual factors including age (OR per 10-year increase 1.12 [95% CI: 1.04-1.20]), female sex (OR 1.29 [1.25-1.34]), non-White race (OR 1.15 [1.10-1.21]), not having private insurance (OR 1.39 [1.27-1.51]) and various comorbidities were strongly associated with 30-day readmission rates, whereas associations with hospital factors including hospital CABG volume, surgeon CABG volume, hospital size, hospital quality and teaching status were inconsistent. CONCLUSIONS: Nearly 1 in 8 CABG patients are readmitted within 30 days and the majority of these are readmitted for noncardiac causes. Readmission rates are strongly influenced by patients' demographic and clinical characteristics, but not by broadly defined hospital characteristics.
Authors: Christian McNeely; Kathleen Kwedar; Stephen Markwell; Christina M Vassileva Journal: J Thorac Cardiovasc Surg Date: 2017-06-10 Impact factor: 5.209
Authors: S A Nashef; F Roques; P Michel; J Cortina; A Faichney; E Gams; A Harjula; M T Jones Journal: Eur J Cardiothorac Surg Date: 2000-04 Impact factor: 4.191
Authors: Habib Khoury; Yas Sanaiha; Sarah E Rudasill; Alexandra L Mardock; Sohail Sareh; Peyman Benharash Journal: Am J Cardiol Date: 2019-04-23 Impact factor: 2.778
Authors: Richard S D'Agostino; Jeffrey P Jacobs; Vinay Badhwar; Felix G Fernandez; Gaetano Paone; David W Wormuth; David M Shahian Journal: Ann Thorac Surg Date: 2018-01 Impact factor: 4.330
Authors: Aleksander Zywot; Christine S M Lau; Nina Glass; Stephanie Bonne; Franchesca Hwang; Koren Goodman; Anne Mosenthal; Subroto Paul Journal: Ann Thorac Surg Date: 2017-12-27 Impact factor: 4.330
Authors: Mohamad Alkhouli; Fahad Alqahtani; Ankur Kalra; Sameer Gafoor; Mohamed Alhajji; Mohammed Alreshidan; David R Holmes; Amir Lerman Journal: JAMA Netw Open Date: 2020-02-05
Authors: Benjamin S Brooke; Philip P Goodney; Larry W Kraiss; Daniel J Gottlieb; Matthew H Samore; Samuel R G Finlayson Journal: Lancet Date: 2015-06-17 Impact factor: 79.321
Authors: Akash Kataruka; Charles C Maynard; Kathleen E Kearney; Ahmed Mahmoud; Sean Bell; Jacob A Doll; James M McCabe; Chistopher Bryson; Hitinder S Gurm; Hani Jneid; Salim S Virani; Eric Lehr; Michael E Ring; Ravi S Hira Journal: J Am Heart Assoc Date: 2020-05-27 Impact factor: 5.501
Authors: Gijs van Steenbergen; Dennis van Veghel; Dideke van Lieshout; Merel Sperwer; Joost Ter Woorst; Lukas Dekker Journal: J Med Internet Res Date: 2022-08-26 Impact factor: 7.076